Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

31 Jan 2007 07:01

Plant Health Care PLC31 January 2007 31 January 2007 Plant Health Care PLC ("Plant Health Care" or "the Company") Directors' Dealings Directors' Exercise of Options The Company was notified on 30 January 2007 that, on the same day, Dr DonaldMarx, a director of the Company, exercised options over 715,761 ordinary sharesof 1p each in the Company ("Ordinary Shares") at an exercise price of 37 penceper Ordinary Share and options over 34,237 Ordinary Shares at an exercise priceof 71 pence per Ordinary Share. Accordingly, on 30 January 2007 Dr Marxexercised a total of 749,998 options over Ordinary Shares. The Company was notified on 30 January 2007 that, on the same day, Mr JohnBrady, a Director of the Company, exercised options over 300,000 Ordinary Sharesat a price of 37 pence per Ordinary Share. Directors' Dealings The Company was notified on 30 January 2007 that, on the same day Dr Marx and MrBrady sold 900,000 Ordinary Shares and 300,000 Ordinary Shares respectively allat a price of 225 pence per Ordinary Share. All of these 1.2 million OrdinaryShares sold by Dr Marx and Mr Brady were as a result of the exercise of options(described above), with the exception of 150,002 Ordinary Shares held by DrMarx. Directors' Interests and Admission of Ordinary Shares Following the exercise of options and share sales described above, thebeneficial interests of the directors in the Company's Ordinary Share capitalare set out below: Name Ordinary Percentage of Share Options Shareholding issued Ordinary Share capital Dr Albert Fischer 143,371 0.35% 225,000John Brady Nil Nil 1,200,000Walter Bratkowski Nil Nil 200,000Dr Robert Chanson 135,166 0.33% 210,000Thomas Isler 400,846 0.97% 202,500Dr Donald Marx 428,813 1.04% 3,470Samuel Wauchope 52,232 0.13% Nil Application has been made for 1,049,998 Ordinary Shares being issued pursuant tothe exercise of options described above, to be admitted to trading on the LondonStock Exchange's AIM market for listed securities ("Admission"). Admission isexpected to occur on 5 February 2007. The New Shares will rank pari passu withthe Company's existing Ordinary Shares. Following admission of the New Shares, the total issued share capital of the Company will be 41,428,422 Ordinary Shares, all of which have voting rights. The above figure (41,428,422) may be used by shareholders as the denominator forthe calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, Plant Health Care plc underthe FSA's Disclosure and Transparency Rules. For further information: Tavistock ComunicationsJeremy Carey/Matt RidsdaleTel: +44 20 7920 3150 Plant Health Care PLCAndrew Wood, Company Secretary Tel: +44 (0) 20 8866 5702 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jul 20242:23 pmRNSForm 8.3 - Plant Health Care plc
1st Jul 20249:46 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 20247:32 amRNSForm 8.3 - Plant Health Care plc
28th Jun 20241:38 pmRNSForm 8.3 - Plant Health Care PLC
28th Jun 202411:35 amRNSForm 8.3 - Plant Health Care plc
28th Jun 202411:31 amRNSResult of GM & AGM
28th Jun 202410:13 amRNSForm 8.3 - Plant Health Care Plc
28th Jun 20249:16 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 20248:59 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20241:03 pmPRNForm 8.3 - Plant Health Care Plc
27th Jun 202412:13 pmRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:43 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:08 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20245:55 pmRNSForm 8.3 - Plant Health Care
26th Jun 20241:23 pmRNSRecommended Cash Acquisition of Plant Health Care
12th Jun 20245:22 pmRNSNotice of General Meeting
5th Jun 20245:09 pmRNSNotice of Annual General Meeting
4th Jun 20247:00 amRNSExpanded New California Label for Employ®
31st May 20245:05 pmRNSFull Year Results
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.